FFC-fed mice progressed from simple steatosis to early non-alcoholic steatohepatitis, along with significantly higher TNFα and IL-6 protein levels in the liver and impaired glucose tolerance. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.